Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
PLA2G2A (Phospholipase A2 group IIA) gives rise to a secreted enzyme categorized within the group-IIA phospholipase A2 family, whose expression is responsive to diverse tissue-derived stimulatory signals. This enzyme possesses a conserved catalytic domain reinforced by extensive disulfide-bond networks, which underpins its capacity to engage phospholipid-containing molecular assemblies in a calcium-associated manner. Post-translational secretory processing directs mature PLA2G2A toward extracellular compartments; portions of the protein can peripherally attach to exposed lipid-membrane interfaces and granular vesicular structures, alongside freely soluble distribution within extracellular milieu.
PLA2G2A is capable of forming transient heteromeric complexes with lipid-rich partner moieties, participating in local extracellular phospholipid-related molecular events. Perturbations to PLA2G2A structural integrity or protein availability can interfere with the assembly of such lipid-centered complexes, shifting local molecular homeostasis within surrounding tissue microenvironments. Tissue inflammatory contexts can drive changes to PLA2G2A abundance, placing this enzyme within the scope of research exploring microenvironment-associated lipid-remodelling events.
Genetic alterations located within the PLA2G2A coding region may disrupt protein folding status, disturb lipid-partner binding interfaces, and modify measurable outputs from enzyme-lipid molecular interactions. Closely related paralogs from the phospholipase A2 family cannot fully duplicate the unique interaction spectrum exhibited by PLA2G2A during heteromeric lipid-complex formation and peripheral membrane-surface engagement. Variations in PLA2G2A protein levels correlate with adaptive tissue demands for extracellular phospholipid processing, rendering this secreted enzyme a valuable research object for dissecting group-IIA phospholipase biology and tissue-level lipid-homeostasis dynamics.
Predominantly localized to extracellular spaces, PLA2G2A may reversibly interact with membrane-surface assemblies yet does not sustain continuous downstream molecular responses without suitable substrate-driven conformational triggers. Its disulfide-stabilized catalytic domain architecture sets it apart from many other secreted lipid-processing proteins, enabling selective reversible contacts with lipid-containing partner assemblies. Impaired functional competence of PLA2G2A is able to disrupt orderly lipid-partner complex arrangement and weaken intrinsic tissue adaptive buffering capacity, further supporting its research significance for biochemical investigations focused on secreted phospholipase-mediated molecular events.
Fig. 1 Ribbon structure of secreted human group IIA phospholipase A2 (PLA2G2A). This extracellular enzyme contains extensive disulfide bond stabilized catalytic domains and a conserved calcium binding site; the protein can reversibly interact with lipid rich membrane associated assemblies.1
The biological functions of secreted PLA2G2A phospholipase-A2 protein are focused on sustained heteromeric partner-complex interaction and tissue lipid-homeostasis coordination:
Creative Biolabs offers purified PLA2G2A recombinant protein samples generated under unified preparation workflows, including full-length enzyme constructs and isolated domain-truncated variants. Truncated domain fragments cannot support complete lipid-partner-complex assembly behaviours, whereas full-length constructs suit research focused on partner-complex interaction and substrate-related functional observation. All batches receive uniform quality screening. Function-oriented observation may only be performed using full-length samples under simulated physiological setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length PLA2G2A samples retain intact partner-interaction-domain conformation after standardized purification, supporting reliable detection of weak and transient enzyme-partner contacts for comparative functional analysis.
Not finding the potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable PLA2G2A expression cell research models with tunable target-expression levels, applicable to structural observation of group-IIA secreted phospholipase-A2 enzyme and research into lipid-partner molecular interaction. Sample evaluation includes sustained target-enzyme expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of binding behaviours under differing target-protein abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting PLA2G2A protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-PLA2G2A recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for protein localization mapping and identification of enzyme-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realise multi-dimensional observation of target-enzyme distribution within experimental sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for PLA2G2A research:
PLA2G2A might act as a group-IIA secreted calcium-dependent phospholipase-A2 enzyme and participate in heteromeric lipid-partner-complex assembly to modulate enzyme-complex arrangement and tissue lipid homeostasis.
PLA2G2A expression status could alter lipid-partner-complex assembly efficiency and local molecular-interaction balance, serving as an important mediator of phospholipid-remodelling-associated tissue-lipid-homeostasis-related biological processes.
No, PLA2G2A-associated research reagents from Creative Biolabs are exclusively built for exploring secreted-phospholipase-dependent molecular regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length PLA2G2A recombinant protein, target-specific recombinant antibodies and tunable-expression cell research models, supporting research on tissue lipid homeostasis and enzyme-mediated lipid-partner perception.
Laboratory observation schemes may include enzyme partner interaction related tests to analyse molecular binding associated behaviours under simulated physiological environments.